Table 3.
Median survival time of F98 glioma bearing Fischer rats
Treatmenta | MSTd (days) | MeSTc (days) | Range (days) | P valuef |
---|---|---|---|---|
5% Dextrose | 22.9 ± 2.1 | 23.5 | 19–25 | |
5% Dextrose + 15 Gyb | 31.8 ± 5.2 | 30.0 | 26–35 | P=0.0002 |
7.5 μg Cisplatinc | 36.1 ± 6.6 | 35.5 | 25–46 | P<0.0001 |
7.5 μg Cisplatin + 15 Gy | 39.3 ± 4.5 | 39.0 | 32–45 | P=0.0002 |
7.5 μgLipoplatin™ | 27.0 ± 2.0 | 26.5 | 25–31 | P=0.0004 |
25 μg Carboplatin | 40.9 ± 6.0 | 38.5 | 31–47 | P<0.0001 |
25 μg Carboplatin + 15 Gy | 53.1 ± 9.6 | 54.0 | 39–65 | P<0.0001 |
Injection volume = 10 μL.
Radiotherapy was delivered 24 h after chemotherapy.
Drugs were tested at their respective MTD.
Mean Survival Time
Median Survival Time
Compared to 5% Dextrose